Cost Effectiveness of Ceritinib and Alectinib Versus Crizotinib in First-Line Anaplastic Lymphoma Kinase-Positive Advanced Non-small-cell Lung Cancer
2019 ◽
Vol 40
(2)
◽
pp. 183-189
◽
2019 ◽
Vol Volume 11
◽
pp. 9195-9202
◽
2014 ◽
Vol 32
(10)
◽
pp. 983-985
◽